MedTrace Logo

Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient a Metabolomics and Proteomics Approach

NCT04764305 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-03-13

No results posted yet for this study

Summary

Out objective is to identify the mechanisms that promote hepatic and myocardial fibrosis, and collateral vessel formation in patients with complex congenital heart disease and Fontan circulation.

Conditions

  • Patient Participation
  • Heart Defects, Congenital
  • Liver Diseases
  • Collateral Circulation, Any Site
  • Myocardial Fibrosis

Sponsors & Collaborators

  • Heart and Diabetes Center North Rhine-Westphalia

    collaborator OTHER

  • Austrian Science Fund (FWF)

    collaborator OTHER

  • Medical University Innsbruck

    lead OTHER

Principal Investigators

  • Miriam Michel, MD · Medical University of Innsbruck

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04764305 on ClinicalTrials.gov